Rockline Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,669
| Closed | -$830K | – | 104 |
|
|
2025
Q1 | $830K | Buy |
1,669
+140
| +9% | +$69.7K | 0.23% | 57 |
|
|
2024
Q4 | $795K | Buy |
1,529
+85
| +6% | +$44.2K | 0.21% | 63 |
|
|
2024
Q3 | $893K | Buy |
1,444
+115
| +9% | +$71.1K | 0.25% | 62 |
|
|
2024
Q2 | $735K | Buy |
1,329
+30
| +2% | +$16.6K | 0.23% | 62 |
|
|
2024
Q1 | $755K | Buy |
1,299
+108
| +9% | +$62.8K | 0.26% | 63 |
|
|
2023
Q4 | $632K | Buy |
+1,191
| New | +$632K | 0.26% | 66 |
|